Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours.
This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Genomic Health, Inc., Novartis Pharmaceuticals Corporation, Pfizer, and Seattle Genetics, Inc.
The optimal care of patients with breast cancer is rapidly changing and becoming increasingly complex as a result of advances in all aspects of management, including screening, molecular/genetic testing, detection, primary treatments (ie, surgery, radiation therapy, and systemic therapies), and patient support strategies. For 36 years, the multidisciplinary Miami Breast Cancer Conference® has been bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists, with the aim of fostering your awareness of state-of-the-art treatments for all stages and subtypes of breast cancer, providing you with expert perspectives on areas of clinical uncertainty or controversy, and encouraging you to engage in cross-team cooperation in your clinic. This year will be no different and will also include a patient communication workshop, specialized programming on issues related to young women with breast cancer, and a frank discussion about physician burnout. Please join us at the 36th Annual Miami Breast Cancer Conference®.
The 36th Annual Miami Breast Cancer Conference®(MBC) is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Genomic Health, Inc., Pfizer, Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc.
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Don’t miss the Thursday Mini-Symposium at the 36th Annual Miami Breast Cancer Conference®, now in a new format! For years, the MBC Mini-Symposium has been a popular educational add-on option. In 2019, this special session will truly follow the format of the Tumor Boards taking place at cancer care institutions around the world. Throughout the day, a series of 15 to 20 breast cancer patient cases will be presented, each highlighting an important clinical challenge being faced by breast cancer care providers like you. A world-class multidisciplinary clinical team, composed of members of the MBC faculty, will share their approaches and perspectives for the questions at hand in the context of current evidence and best practices, with the ultimate goal of reaching consensus toward management. This special session, to be delivered by top experts in the field of breast cancer, was developed to be of interest to practitioners from all specialties, and will provide practical information to enhance patient care in your clinic.
If your schedule allows, we at Physicians' Education Resource hope you will plan to attend and take advantage of this valuable extra session!
Note: Separate registration is required.
Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Elizabeth Mittendorf, MD, PhD
Robert and Karen Hale Distinguished Chair in Surgical Oncology
Director, Breast Immuno-Oncology Program
Dana-Farber/Brigham and Women's Cancer Center
Hope S. Rugo, MD, FASCO
Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
For more on this oncology CME, view highlights from last year's meeting.
Dec 31, 2018
Medical Crossfire®: Defining New Roles for the Application of PARP Inhibition Strategies in Multiple Tumor Types
Dec 31, 2018
Dec 31, 2018